DeCampli William M, Argueta-Morales I Ricardo, Zabinsky Jennifer, Hannan Robert L, Burke Redmond P
The Congenital Heart Institute, Arnold Palmer Hospital for Children, Orlando, and Miami Children's Hospital, Miami, Florida, United States of America.
Cardiol Young. 2010 Dec;20 Suppl 3:128-34. doi: 10.1017/S1047951110001186.
Tetralogy of Fallot with pulmonary atresia and diminutive or absent intrapericardial pulmonary arteries is a rare congenital abnormality, with high morbidity and mortality. Despite great advances in surgical- and catheter-based therapies, management remains challenging and controversial. We describe the surgical methods and the results from our institution.
We performed a retrospective study of the medical records of patients included in our institutional database with tetralogy and pulmonary atresia, concentrating on those predominantly managed by our programme over their lifetime. We obtained demographics and records of all catheterisations and operations, and established mortality. We assessed the current state of those surviving in terms of clinical function at their most recent clinical evaluation and right ventricular function by echocardiography.
We assessed 38 patients, with 89% follow-up. The mean number of catheterisations for each patients was 5, with a range from 1 to 15. The mean number of operations was 2.2, with a range from 1 to 6. Unifocalisation had been performed in 26 patients, with 12 undergoing procedures to recruit the native pulmonary vasculature. Of the overall cohort, eight patients died. The ventricular septal defect had been closed in all but two patients. Most patients have no or mild exercise intolerance. Right ventricle dysfunction has been a continuing hazard for 15 years.
An individualised approach, using unifocalisation as well as aggressive attempts to recruit the available native pulmonary vasculature, achieves outcomes in the intermediate term superior to the natural history of the lesions, and comparable with those of other studies.
法洛四联症合并肺动脉闭锁且心包内肺动脉细小或缺如,是一种罕见的先天性异常,发病率和死亡率都很高。尽管在手术和导管介入治疗方面取得了巨大进展,但治疗管理仍然具有挑战性且存在争议。我们描述了我们机构的手术方法及结果。
我们对机构数据库中患有法洛四联症和肺动脉闭锁的患者病历进行了回顾性研究,重点关注那些在其一生中主要由我们的项目管理的患者。我们获取了所有导管介入和手术的人口统计学资料及记录,并确定了死亡率。我们通过超声心动图评估了存活患者在最近一次临床评估时的临床功能和右心室功能的当前状态。
我们评估了38例患者,随访率为89%。每位患者的平均导管介入次数为5次,范围为1至15次。平均手术次数为2.2次,范围为1至6次。26例患者进行了单源化手术,其中12例接受了募集固有肺血管系统的手术。在整个队列中,有8例患者死亡。除2例患者外,所有患者的室间隔缺损均已闭合。大多数患者无运动不耐受或仅有轻度运动不耐受。右心室功能障碍在15年里一直是个危险因素。
采用单源化以及积极募集可用的固有肺血管系统的个体化方法,在中期可取得优于病变自然病程的结果,且与其他研究结果相当。